Oncolytic Vaccinia Virus Armed With CLEC2A Enhances Antitumor Immunity via ROS‐Autophagy Feedback Loop and Cytokine Activation
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Jiawei Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Sciences…. Hauptthemen laut MEDLINE: Vaccinia virus, Reactive Oxygen Species, Autophagy, Cytokines. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Funding for this research project was provided by the National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Tumors often exhibit immunosuppressive microenvironments (TMEs) and present as immunologically “cold.” Oncolytic viruses (OVs), particularly engineered vaccinia viruses (oncoVVs), are an encouraging therapy that directly lyses cancer cells and reprograms the TME. In this study, we evaluated the therapeutic potential of an oncolytic vaccinia virus expressing human C‐type lectin domain family 2 member A (oncoVV‐CLEC2A) in melanoma and ovarian cancer cells. OncoVV‐CLEC2A elevated reactive oxygen species (ROS) levels, suppressed Nrf2‐mediated antioxidant responses, and triggered autophagy. These changes promoted cytokine production (IL‐6, IFN‐α/β/γ, TNF‐α) via activation of AP‐1 and IRF3/7. In a B16‐F10 melanoma model, oncoVV‐CLEC2A increased serum levels of IFN‐γ, accompanied by augmented infiltration of CD8 + T cells and activation of NK cells. Taken together, oncoVV‐CLEC2A reshapes the TME by intensifying oxidative stress and autophagic activity, effectively turning “cold” tumors “hot.” Notably, the mutual reinforcement between ROS production and autophagy activation not only enhances viral replication but also triggers cytokine‐mediated immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
ORCID-Profile: Ruikang Liu, Kan Chen, Yanrong Zhou, Ting Ye, Gongchu Li
Förderung
- Funding for this research project was provided by the National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Su, J., Zhai, C., Li, Y., Liu, R., Zhu, J., Chen, K., Zhou, Y., Ye, T., & Li, G. (2026). Oncolytic Vaccinia Virus Armed With CLEC2A Enhances Antitumor Immunity via ROS‐Autophagy Feedback Loop and Cytokine Activation. Journal of Medical Virology. https://doi.org/10.1002/jmv.71174
Vancouver
Su J, Zhai C, Li Y, Liu R, Zhu J, Chen K, et al. Oncolytic Vaccinia Virus Armed With CLEC2A Enhances Antitumor Immunity via ROS‐Autophagy Feedback Loop and Cytokine Activation. Journal of Medical Virology. 2026. doi:10.1002/jmv.71174
BibTeX
@article{Su2026,
author = {Su, Jiawei and Zhai, Chunlian and Li, Yuxin and Liu, Ruikang and Zhu, Jili and Chen, Kan and Zhou, Yanrong and Ye, Ting and Li, Gongchu},
title = {Oncolytic Vaccinia Virus Armed With CLEC2A Enhances Antitumor Immunity via ROS‐Autophagy Feedback Loop and Cytokine Activation},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71174}
}
EUVIMED